← Back to Search

Visual Feedback Training for Aphasia

N/A
Waitlist Available
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
A significant proportion of aphasic patients may show symptoms associated with Apraxia of Speech (AOS) or dysarthria, however, these patients will not be excluded unless their deficits preclude them from performing the experimental tasks
Age range 21-75 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Study Summary

This trial looks at different types of feedback people with aphasia get when speaking to see what helps them communicate better.

Who is the study for?
This trial is for English-speaking adults aged 21-75 who have aphasia after a stroke, can perform the study tasks, and have no severe hearing or cognitive issues. Healthy controls with normal speech and no neurological disorders are also needed. Both groups must be right-handed.Check my eligibility
What is being tested?
The study tests how visual feedback training affects speech in people with aphasia by using EEG and fMRI to track brain activity during speech tasks under altered auditory conditions. It aims to improve communication abilities and develop targeted treatments.See study design
What are the potential side effects?
There may not be direct side effects from the interventions as this is a non-invasive study involving behavioral training and brain imaging techniques like EEG and MRI.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have speech difficulties but can still do the required tasks.
Select...
I am between 21 and 75 years old.
Select...
I have never had a neurological or psychiatric disorder.
Select...
My voice, speech, language, and hearing are normal.
Select...
I have been diagnosed with a specific type of aphasia.
Select...
I have had aphasia from a stroke in the left side of my brain for over 6 months.
Select...
I am a native English speaker.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Speech Production and Motor Control Ability

Trial Design

2Treatment groups
Experimental Treatment
Group I: Control GroupExperimental Treatment1 Intervention
Group II: Aphasia GroupExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas at DallasLead Sponsor
57 Previous Clinical Trials
106,142 Total Patients Enrolled
3 Trials studying Aphasia
62 Patients Enrolled for Aphasia
University of South CarolinaLead Sponsor
210 Previous Clinical Trials
120,409 Total Patients Enrolled
6 Trials studying Aphasia
521 Patients Enrolled for Aphasia

Media Library

Visual Feedback Training Clinical Trial Eligibility Overview. Trial Name: NCT04742894 — N/A
Aphasia Research Study Groups: Aphasia Group, Control Group
Aphasia Clinical Trial 2023: Visual Feedback Training Highlights & Side Effects. Trial Name: NCT04742894 — N/A
Visual Feedback Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT04742894 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there certain individuals who would be more suited for this medical experiment?

"This clinical trial is searching for 100 individuals between the ages of 21 to 75 with aphasia. The participants should be English speakers, right-handed and diagnosed with one type of this disorder (i.e., Broca's, Wernicke's, conduction or anomic). Control group members must have normal voice, speech, language and hearing functions without any neurological or psychiatric history. Those showing signs associated to Apraxia of Speech will not be excluded so long as they are capable to complete the experimental tasks."

Answered by AI

What is the aggregate participant count of this clinical experiment?

"Affirmative. According to clinicaltrials.gov, this experimental therapy is currently enrolling participants that began on July 11th 2021 and was most recently updated March 21st 2022. The trial seeks a total of 100 individuals from one medical facility."

Answered by AI

Can individuals who are 40 years of age and above participate in this medical research?

"This study is open to those aged 21-75, whereas there are 5 trials specifically for minors and 86 studies targeting seniors."

Answered by AI
~67 spots leftby Feb 2026